Clearmind Medicine Inc.

Nasdaq:CMND

Pharmaceutical Preparations·VANCOUVER, BRITISH COLUMBIA, Z4

Prospectuses & Registrations

35 shown

Filed	Form	Description
2/17/26	F-3	REGISTRATION STATEMENT	→
12/5/25	F-1/A	AMENDMENT NO. 1 TO FORM F-1	→
12/3/25	424B5	PROSPECTUS SUPPLEMENT	→
11/26/25	F-1	REGISTRATION STATEMENT	→
11/26/25	424B5	PROSPECTUS SUPPLEMENT	→
11/19/25	424B5	PROSPECTUS SUPPLEMENT	→
↓

Ownership

9 shown

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
2/14/24	SC 13G	SC 13G	→
2/6/24	SC 13G/A	AMENDMENT NO. 1 TO SCHEDULE 13G	→
1/22/24	SC 13G	SC 13G	→
10/26/23	SC 13G	ELI POLATOV SCHEDULE 13G	→
9/5/23	SC 13G/A	AMENDMENT NO. 1 TO SCHEDULE 13G	→
↓

Other Filings

40 shown

Filed	Form	Description
3/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/26/26	EFFECT	EFFECT	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/30/26	EFFECT	EFFECT	→
1/30/26	EFFECT	EFFECT	→
1/30/26	EFFECT	EFFECT	→
↓

Filing History(292 filings)

TypeDateAccessionPeriodSize

6-K

Mar 10, 2026

0001213900-26-025476REPORT OF FOREIGN PRIVATE ISSUER

Mar 10, 2026

30.6 KB

SCHEDULE 13G/A

Mar 9, 2026

0001213900-26-025210

—

7.1 KB

6-K

Mar 4, 2026

0001213900-26-023431REPORT OF FOREIGN PRIVATE ISSUER

Mar 4, 2026

30.4 KB

EFFECT

Feb 26, 2026

9999999995-26-000680

—

1.7 KB

F-3

Feb 17, 2026

0001213900-26-017379REGISTRATION STATEMENT

—

600.1 KB

6-K

Feb 17, 2026

0001213900-26-017373REPORT OF FOREIGN PRIVATE ISSUER

Feb 17, 2026

12.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0000930413-26-000424

—

12.9 KB

6-K

Feb 11, 2026

0001213900-26-014905REPORT OF FOREIGN PRIVATE ISSUER

Feb 11, 2026

32.3 KB

6-K

Feb 9, 2026

0001213900-26-013478REPORT OF FOREIGN PRIVATE ISSUER

Feb 9, 2026

26.3 KB

6-K

Feb 6, 2026

0001213900-26-013062REPORT OF FOREIGN PRIVATE ISSUER

Feb 6, 2026

29.8 KB

6-K

Feb 4, 2026

0001213900-26-012245REPORT OF FOREIGN PRIVATE ISSUER

Feb 4, 2026

12.2 KB

6-K

Feb 3, 2026

0001213900-26-011078REPORT OF FOREIGN PRIVATE ISSUER

Feb 3, 2026

26.2 KB

EFFECT

Jan 30, 2026

9999999995-26-000371

—

1.7 KB

EFFECT

Jan 30, 2026

9999999995-26-000388

—

1.7 KB

EFFECT

Jan 30, 2026

9999999995-26-000361

—

1.7 KB

POS AM

Jan 27, 2026

0001213900-26-008233POST-EFFECTIVE AMENDMENT NO. 8 TO FORM F-1

—

398.4 KB

POS AM

Jan 27, 2026

0001213900-26-008228POST-EFFECTIVE AMENDMENT NO. 8 TO FORM F-1

—

398.4 KB

POS AM

Jan 27, 2026

0001213900-26-008227POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1

—

362.5 KB

20-F

Jan 20, 2026

0001213900-26-005665ANNUAL REPORT

Oct 31, 2025

8.3 MB

6-K

Jan 14, 2026

0001213900-26-004181REPORT OF FOREIGN PRIVATE ISSUER

Jan 14, 2026

31.6 KB

6-K

Dec 31, 2025

0001213900-25-126834REPORT OF FOREIGN PRIVATE ISSUER

Dec 31, 2025

24.5 KB

6-K

Dec 29, 2025

0001213900-25-125574REPORT OF FOREIGN PRIVATE ISSUER

Dec 29, 2025

26.2 KB

6-K

Dec 16, 2025

0001213900-25-121941REPORT OF FOREIGN PRIVATE ISSUER

Dec 16, 2025

26.1 KB

6-K

Dec 12, 2025

0001213900-25-120956REPORT OF FOREIGN PRIVATE ISSUER

Dec 12, 2025

40.8 KB

6-K

Dec 12, 2025

0001213900-25-120918REPORT OF FOREIGN PRIVATE ISSUER

Dec 12, 2025

31.5 KB

25 filings shown